Navamedic's glucosamine HCl product approved in 19 European countries for treatment of osteoarthritis
19-Jan-2006 -
Based on the approval of Glucomed®, granted by the Swedish Medical Products Agency on 4 August 2005, Navamedic launched an MRP application in 24 additional EU/EEA countries on 18 October. The 90 day procedure thus ended on 16 January 2006 and Navamedic has received notice that its product has ...
arthritis
Belgium
Cyprus
+19